The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Iovance Biotherapeutics Inc’s current trading price is -46.97% away from its 52-week high, while its distance from the 52-week low is 202.80%. The stock’s price range for this period has been between $3.21 and $18.33 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.46 million for the day, a number notably lower than the average daily volume of 6.26 million over the last three months.
Iovance Biotherapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $18.33 on 02/28/24 and the lowest value was $3.21 on 10/19/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 24.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.95B and boasts a workforce of 557 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.30, with a change in price of -0.96. Similarly, Iovance Biotherapeutics Inc recorded 6,572,190 in trading volume during the last 100 days, posting a change of -8.99%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.
IOVA Stock Stochastic Average
Iovance Biotherapeutics Inc’s raw stochastic average for the past 50 days is presently 48.42%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 38.27%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 57.36% and 57.67%, respectively.
IOVA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded an increase of 19.56%. However, over the last six months, the performance has been stronger by -26.48%. The price of IOVA decreased -1.42% over the last 30 days. And in the last five days, it has surged by 3.96%.
